access pharmaceuticals inc. Resources | BNET
On CBS News: Senator Lieberman: We may be attacked

BNET Industries

Access Pharmaceuticals Inc. (ACCP) is in the Pharma Industry

Revenue
Dec 31 2007
$57.0K
Profit
Dec 31 2007
($36.6M)
Market Cap
Jul 02 2008
$16.9M

Latest News and Analysis

Additional Resources

  • Incorporated: 1974
  • CEO: Mr. Jeffrey B. Davis
  • Employees: 10

Access Pharmaceuticals is a biopharmaceutical company developing products for use in the treatment of cancer, the supportive care of cancer, and other disease states. As of Dec 31 2006, Co.'s key clinical development program for its drug candidate ProLindac? is in Phase II clinical testing. In addition, Co. is developing other drug delivery technologies including Cobalamin?-mediated oral drug delivery and targeted delivery. Together with its subsidiaries, Co. has proprietary patents or rights to three drug delivery technology platforms, including synthetic polymer targeted delivery, cobalamin-mediated delivery, and mucoadhesive liquid technology.

Key Competitors

advertisement
Access Pharmaceuticals Inc. Company Info

Board of Directors

Mr. J. Michael Flinn

Chairman

Dr. Rosemary Mazanet M.D., Ph

Mr. Steven H. Rouhandeh

Chairman

Dr. Stephen B. Howell M.D.

Mr. Herbert H. McDade Jr.

Mr. Mark V. Alvino

Mr. John J. Meakem Jr.

Mr. Jeffrey B. Davis

Dr. Mark J. Ahn Ph.D.

Dr. Estaban Cvitkovik M.D.

Contact Information

2600 Stemmons Freeway

Suite 176

Dallas, TX

http://www.accesspharma.com

214 905-5100

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement